Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Oncologist
; 22(6): 737-742, 2017 06.
Article
en En
| MEDLINE
| ID: mdl-28533476
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Linfocitos
/
Biomarcadores de Tumor
/
Carcinoma de Pulmón de Células no Pequeñas
/
Recurrencia Local de Neoplasia
/
Neutrófilos
Tipo de estudio:
Prognostic_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2017
Tipo del documento:
Article